Koenig Scott — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Koenig Scott has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Profile

Koenig Scott

Scott Koenig is the President and CEO of Macrogenics Inc, a biotechnology company focused on developing antibody-based therapeutics for cancer treatment. He has played a significant role in advancing the company's clinical pipeline and strategic direction.

RoleDirector
Notability30/100

Board memberships

Awards & honors

Recent Transactions

DateTickerCompanyCodeSharesPriceValue
2026-02-17MGNXMACROGENICS INCM — Option exercise21.2K$0.00
2026-02-10MGNXMACROGENICS INCM — Option exercise15.8K—
2025-08-13MGNXMACROGENICS INCM — Option exercise31.7K$0.00
2025-08-13MGNXMACROGENICS INCM — Option exercise21.2K$0.00
2024-10-09MGNXMACROGENICS INCG — Bona-fide gift53.3K—
2024-10-09MGNXMACROGENICS INCG — Bona-fide gift53.3K—

Companies — Last 90 Days

Frequently Asked Questions

Who is Koenig Scott?

Scott Koenig is the President and CEO of Macrogenics Inc, a biotechnology company focused on developing antibody-based therapeutics for cancer treatment. He has played a significant role in advancing the company's clinical pipeline and strategic direction.…

How many SEC Form 4 filings has Koenig Scott submitted recently?

1 primary Form 4 filings in the last 90 days, covering 1 company.

Where can I see all of Koenig Scott's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

Open the live Koenig Scott profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.